Escherichia coli strain CT301

TA loci of Escherichia coli strain CT30

Number of TA loci: experimental0; insolico32

TA ID Related MGEs Organism (replicon) Genome accession Toxin Antitoxin Family/Domain
in_silico TA111019 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS01630 (hicA) D2195_RS01635 (hicB) hicAB/-
in_silico TA111020 Prophage Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS01785 (doc) D2195_RS01780 (phd) phd-doc/Doc-RelB
in_silico TA111021 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS03365 (yhaV) D2195_RS03370 (prlF) prlF-yhaV (relBE)/YhaV-PrlF
in_silico TA111024 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS06940 (vapC) D2195_RS06935 (vapB) vapBC/VapC-VagC
in_silico TA111025 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS09500 (Hha) D2195_RS09505 (TomB) Hha-TomB/-
in_silico TA111026 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS09615 (higB) D2195_RS09620 (higA) higBA (relBE)/HigB-HTH_XRE
in_silico TA111027 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS11555 (relE) D2195_RS11550 (relB) relBE/RelE-HTH_XRE
in_silico TA111028 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS12725 (TacT2) D2195_RS12730 (TacA2) tacAT/DUF1778(antitoxin)
in_silico TA111029 GI Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS14250 (hicA) D2195_RS14255 (hicB) hicAB/UPF0150(antitoxin)
in_silico TA111030 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS14610 (hipA) D2195_RS14615 (hipB) hipBA/HipA-HipB
in_silico TA111039 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS17665 (yoeB) D2195_RS17670 (yefM) yefM-yoeB (relBE)/YoeB-YefM
in_silico TA111044 - Escherichia coli strain CT30 (chromosome) NZ_CP032078 D2195_RS22930 (higB) D2195_RS22925 (higA) higBA (relBE)/HTH(antitoxin)
in_silico TA111045 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P1) NZ_CP032079 D2195_RS24145 (hipA) D2195_RS24150 (hipB) hipBA/HipA-HipB
in_silico TA111049 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P2) NZ_CP032080 D2195_RS25360 (relE) D2195_RS25365 (relB) relBE/ParE-YafN
in_silico TA111054 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P2) NZ_CP032080 D2195_RS25430 (vapC) D2195_RS25425 (vapB) vapBC/VapC-VagC
in_silico TA111055 Plasmid IS/Tn Escherichia coli strain CT30 (plasmid p.CT30-P2) NZ_CP032080 D2195_RS25475 (vagD) D2195_RS25480 (vagC) vagCD/VapC-VagC
in_silico TA111056 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P2) NZ_CP032080 D2195_RS25545 (parE) D2195_RS25540 (parD) parDE/RelE-RHH
in_silico TA111057 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P3) NZ_CP032081 D2195_RS25615 (TsxA) D2195_RS25620 (TsxB) TsxAB/Xre(antitoxin)
in_silico TA111058 Plasmid Escherichia coli strain CT30 (plasmid p.CT30-P3) NZ_CP032081 D2195_RS25855 (relE) D2195_RS25860 (relB) relBE/ParE-DnaT
experimentalExperimentally validated     insolicoBioinformatically predicted